We focused on mTOR because it is activated by ER stress and inhibition of the mTOR downstream target S6 kinase (S6K) hinders ER stress-induced insulin resistance without affecting the levels of ER stress markers [18]. The gene discussed is RPS6KB1; the disease is Insulin resistance.